Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IBRX · against 161 other Healthcare companies of similar size
Ranked #1 of 162 · scores higher than 100% of peers
Bars: peers in each 10-point band of the growth score20 peers with a growth score of 90–100, including IBRX · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | IBRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 162 reported | 192.9% | 10.2% | 98% | 33% | |
| Earnings per share growthHigher is better · 116 reported | Not reported | 12.0% | — | — | 33% |
| 3-year revenue growthHigher is better · 156 reported | 554.3% | 10.7% | 100% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 2 | 9.3B USD | 98 | 64 | |
| 4 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 4 | 7.3B USD | 97 | 74 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score